Whilst I will probably get moderated for this post, I thought I would remind people of the Inside Wall Street article published in October 2011 titled "Is This Tiny Aussie Biotech the Next Dendreon".
http://www.dailyfinance.com/story/investing/inside-wall-street-is-this-tiny-aussie-biotech-thenextdendreo/19662217/
Just one quote from the article:
"If CVac succeeds in its goals, Prima could be as big if not bigger than Dendreon. That's because CVac is "directed toward the mucin-1 antigen and may target other cancers that overexpress mucin-1, such as ovarian, breast, lung, colon and pancreatic cancer," says Kolbert. The potential market for the full range of mucin-1 targeting those therapies, if successful, "would likely be several times larger than the market for Provenge," says National Securities' Kolbert.
Stuart Roberts, an analyst at Southern Cross Securities in Sydney, Australia, says the upcoming Phase IIb and Phase III clinical trials will potentially provide the catalyst "to unlock the commercial revenues to Prima BioMed through licensing deals that would yield upfront and milestone payments, as well as royalties."
Stay patient people...the rewards will come!
- Forums
- ASX - By Stock
- IMM
- bigger than dendreon
bigger than dendreon
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 33.5¢ | $77.86K | 230.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 158346 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 16557 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 52154 | 0.335 |
11 | 185236 | 0.330 |
11 | 75854 | 0.325 |
9 | 156187 | 0.320 |
3 | 182000 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 79760 | 8 |
0.345 | 156858 | 6 |
0.350 | 96004 | 7 |
0.355 | 121566 | 7 |
0.360 | 151067 | 9 |
Last trade - 10.28am 30/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online